PFAS, Asbestos, And Balance
11:48–12:40 · 52s
Iyer draws a cautionary parallel to asbestos, arguing we’ve leaned too far toward innovation without early health evaluation.
11:48–12:40 · 52s
Iyer draws a cautionary parallel to asbestos, arguing we’ve leaned too far toward innovation without early health evaluation.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.